VOYA Investment Management
BCAX

VOYA Investment Management’s Bicara Therapeutics BCAX Stock Holding History

VOYA Investment Management’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.71M Buy
91,363
+73,355
+407% +$1.64M ﹤0.01% 1113
2026
Q1 		$358K Sell
18,008
-187
-1% -$3.22K ﹤0.01% 1874
2025
Q4 		$306K Buy
+18,195
New +$311K ﹤0.01% 1964

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VOYA Investment Management's BCAX Position: Q2 2026 in Review

VOYA Investment Management increased its Bicara Therapeutics (BCAX) stake by 407% in Q2 2026, buying an estimated $1.64M and bringing the position to 91,363 shares worth $2.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1113.

VOYA Investment Management first reported a position in BCAX in Q4 2025 and has held it in 3 quarters since. 172 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.

  • VOYA Investment Management held 91,363 shares of Bicara Therapeutics worth $2.71M as of Q2 2026.
  • VOYA Investment Management bought 73,355 Bicara Therapeutics shares in Q2 2026, an estimated $1.64M.
  • Bicara Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1113 holding.
  • VOYA Investment Management first reported a position in Bicara Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 172 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.